Academic Conference
Celebrating Heer Medical's Great Success at the 8th China Pathology Annual Conference of the Pathology Branch of the Chinese Medical Association
In October 2018, the 8th China Pathology Annual Conference of the Pathology Branch of the Chinese Medical Association was held in Chengdu. Heer Medical exhibited the multispectral DNA quantitative analysis system; the artificial intelligence application of DNA ploidy analysis technology was widely recognized, with the latest research data from Beijing Hospital showing it can reduce slide-reading workload by 87.7%.
In the golden autumn of October, with the sweet fragrance of osmanthus in the air, the 8th China Pathology Annual Conference of the Pathology Branch of the Chinese Medical Association was held grandly in the beautiful city of Chengdu, Sichuan from October 12 to 14, 2018. Mr. Ren Dalong, Deputy General Manager of Xinkaiyuan Group and founder of Heer Medical, led key company representatives to attend this conference. Under the care of the leadership of the Pathology Branch of the Chinese Medical Association and through the joint efforts of all attending delegates, the conference concluded successfully after three days of lively and intensive exchanges.
More than a thousand cytopathology experts, directors, and technical specialists from across China and internationally attended this conference. During the event, the company's main products — the "Multispectral DNA Quantitative Analysis System," "Fully Automatic Staining Machine," and "Fully Automatic Slide Preparation Machine" — attracted a large number of experts to stop and observe. Company technicians gave detailed demonstrations of instrument operation to every attendee, answered questions, actively communicated and engaged in in-depth exchanges, and discussed the clinical application and market prospects of DNA ploidy analysis technology with numerous distributors, further expanding the company's reputation and influence within the industry.
During the conference, the artificial intelligence application of DNA ploidy analysis technology was widely recognized. After two years of experimental and comparative research between Beijing Hospital and Heer Medical, the latest research data demonstrated that cellular DNA ploidy quantitative analysis is highly consistent with conventional cytology, shows high sensitivity for high-grade lesions, and when combined with conventional cytology, allowing cytological screening to start from abnormal DNA ploidy quantitative analysis, can reduce the slide-reading workload by 87.7%.
